Physician
Win, Aye-Aye
Win, Aye-Aye was paid $917.32 by Medicaid between Jan 2018 and Dec 2024, across 55 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 71% of everything it billed.
33Billing provider infoWIN, AYE-AYE
LOS ANGELES, CA 90003
LOS ANGELES, CA 90003
33aNPI1548366511assigned 09/16/2006
33bProvider typeInternal Medicine Physician
28Total paid$917.32
24GClaims24,975
24DCodes billed55
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in California
Rank by total paid#2,077 of 2,679
Median peer was paid$13K
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,332 | $519.22 | |
| 2019 | 1,149 | $398.10 | |
| 2020 | 3,408 | $0.00 | |
| 2021 | 3,931 | $0.00 | |
| 2022 | 1,711 | $0.00 | |
| 2023 | 1,420 | $0.00 | |
| 2024incomplete | 12,024 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 71% | 2,150 | 1,738 | $654.44 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 29% | 1,812 | 1,537 | $262.88 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 2,084 | 2,067 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 1,757 | 1,580 | $0.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 459 | 449 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 496 | 494 | $0.00 |
| 85027 | 0% | 1,106 | 1,081 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 111 | 111 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 3,824 | 3,446 | $0.00 |
| 99443 | 0% | 458 | 423 | $0.00 | |
| 82043 | 0% | 362 | 353 | $0.00 | |
| 1220F | 0% | 313 | 310 | $0.00 |
43 more codes
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 375 | $0.00 |
| 3044F | 0% | 333 | $0.00 | |
| 90686 | 0% | 12 | $0.00 | |
| 3075F | 0% | 278 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 962 | $0.00 |
| 4450F | 0% | 404 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 195 | $0.00 |
| 3079F | 0% | 258 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 86 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 337 | $0.00 |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 222 | $0.00 |
| 86593 | 0% | 25 | $0.00 | |
| 3074F | 0% | 797 | $0.00 | |
| 3080F | 0% | 34 | $0.00 | |
| 87340 | 0% | 38 | $0.00 | |
| 86780 | 0% | 114 | $0.00 | |
| 81001 | 0% | 47 | $0.00 | |
| 1111F | 0% | 300 | $0.00 | |
| 86592 | 0% | 16 | $0.00 | |
| 90656 | 0% | 52 | $0.00 | |
| 86706 | 0% | 33 | $0.00 | |
| D0140 | Limited oral evaluation - problem focused | 0% | 12 | $0.00 |
| 86703 | 0% | 435 | $0.00 | |
| 80061 | Lipid panel | 0% | 1,630 | $0.00 |
| 99442 | 0% | 257 | $0.00 | |
| 90653 | 0% | 14 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 111 | $0.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 61 | $0.00 |
| 3051F | 0% | 26 | $0.00 | |
| 3077F | 0% | 316 | $0.00 | |
| 3078F | 0% | 1,032 | $0.00 | |
| 82540 | 0% | 362 | $0.00 | |
| 82274 | 0% | 188 | $0.00 | |
| 84450 | 0% | 123 | $0.00 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 0% | 408 | $0.00 |
| 3046F | 0% | 17 | $0.00 | |
| 84439 | 0% | 25 | $0.00 | |
| 84460 | 0% | 13 | $0.00 | |
| 90658 | 0% | 29 | $0.00 | |
| 86708 | 0% | 15 | $0.00 | |
| 85610 | 0% | 18 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 12 | $0.00 |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.